Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QP001 injection for moderate to severe postoperative pain after abdominal surgery
ChiCTR2300075629Phase 3Completed
- Sponsor
- Renji Hospital
- Start
- Oct 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of QP001 in postoperative pain (2 arms), sponsored by Renji Hospital. Primary endpoint: Area under the pain intensity time curve at rest after awakening from anesthesia from 0 to 24 hours. Started Oct 2022; status: completed.
02
Drugs
QP001
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300075629.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300075629.